ANDA 76092, held by Eugia Pharma. Ketamine Hydrochloride.
As of Nov 16, 2026, ANDA 76092 (Ketamine Hydrochloride), held by Eugia Pharma, was first approved by FDA on Dec 28, 2001, with 8 approved supplements and 0 published complete response letters.
Ketamine hydrochloride injection is indicated: as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. for the induction of anesthesia prior to the administration of other general anesthetic agents. as a supplement to other anesthetic agents.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 28, 2001 | Original application | Approved |
| Ketamine HydrochlorideEQ 10MG BASE/ML · injectable;injection | Ketamine Hydrochloride | Rx |
| Ketamine HydrochlorideEQ 50MG BASE/ML · injectable;injection | Ketamine Hydrochloride | Rx |
| Ketamine HydrochlorideEQ 100MG BASE/ML · injectable;injection | Ketamine Hydrochloride | Rx |
| Sep 22, 2026 | Supplement 32Manufacturing | Approved | None posted |
| Sep 15, 2026 | Supplement 31Labeling · Standard review | Approved | None posted |
| Jun 23, 2023 | Supplement 29Labeling · Standard review | Approved | None posted |
| Dec 31, 2018 | Supplement 23Labeling · Standard review | Approved | None posted |
| Oct 5, 2012 | Supplement 18Labeling · Standard review | Approved | None posted |
| Sep 30, 2008 | Supplement 9Labeling | Approved | None posted |
| Oct 25, 2002 | Supplement 1Manufacturing | Approved | None posted |
| Oct 25, 2002 | Supplement 2Labeling | Approved | None posted |
| Dec 28, 2001 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters